10.03.2013
- Drugmaker Elan is to bring forward a planned $1 billion share buyback to next week, the Irish company said in a statement, a move that could undermine a takeover offer by U.S...
25.02.2013
- Investment firm Royalty Pharma has made a $6.6 billion bid approach to Elan, seeking to scupper the Irish drugmaker's plan to spend most of the proceeds from a major drug sale on...
